LENVIMA
Identification of Lenvima
| No description |
Google image searchProduct monograph
Active ingredient
lenvatinib (lenvatinib mesylate), 18 MG/DOSE
DIN: 02468239
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Description: EACH 18 MG DAILY DOSE CONTAINS 1 X 10 MG & 2 X 4 MG CAPSULES PER BLISTER
Schedule: Prescription
Company: EISAI LIMITED
Date: 08-MAY-2018
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX08 — LENVATINIB (ATC/DDD)
Pharmaceutical standard: MFR
